Gerik, L., 2017. On the Frontline of TAVR Research: An Interview With Michael Reardon, M.D.. Methodist DeBakey Cardiovascular Journal, 13(3), pp.e6–e8. DOI: http://doi.org/10.14797/mdcvj.758

Gerik L. On the Frontline of TAVR Research: An Interview With Michael Reardon, M.D.. Methodist DeBakey Cardiovascular Journal. 2017;13(3):e6–8. DOI: http://doi.org/10.14797/mdcvj.758

Gerik, L. (2017). On the Frontline of TAVR Research: An Interview With Michael Reardon, M.D.. Methodist Debakey Cardiovascular Journal, 13(3), e6–e8. DOI: http://doi.org/10.14797/mdcvj.758

1. Gerik L. On the Frontline of TAVR Research: An Interview With Michael Reardon, M.D.. Methodist DeBakey Cardiovascular Journal. 2017;13(3):e6-e8. DOI: http://doi.org/10.14797/mdcvj.758

Gerik L, ‘On the Frontline of TAVR Research: An Interview with Michael Reardon, M.D.’ (2017) 13 Methodist DeBakey Cardiovascular Journal e6 DOI: http://doi.org/10.14797/mdcvj.758

Gerik, Laura. 2017. “On the Frontline of TAVR Research: An Interview with Michael Reardon, M.D.”. Methodist Debakey Cardiovascular Journal 13 (3): e6–e8. DOI: http://doi.org/10.14797/mdcvj.758

Gerik, Laura. “On the Frontline of TAVR Research: An Interview with Michael Reardon, M.D.”. Methodist Debakey Cardiovascular Journal 13, no. 3 (2017): e6–e8. DOI: http://doi.org/10.14797/mdcvj.758

Gerik, L. “On the Frontline of TAVR Research: An Interview With Michael Reardon, M.D.”. Methodist Debakey Cardiovascular Journal, vol. 13, no. 3, 2017, pp. e6–e8. DOI: http://doi.org/10.14797/mdcvj.758